is semaglutide or tirzepatide better for weight loss vs Tirzepatide: Key Differences Tirzepatide vs Semaglutide: Which Is

This trial includes a 52-week extension phase investigating weight loss maintenance REDEFINE 9, an efficacy trial comparing CagriSema to placebo in adults with obesity or overweight, lasting 68 weeks and enrolling 300 patients REDEFINE 11, an efficacy trial of CagriSema compared to placebo in patients with obesity, lasting 80 weeks and enrolling 600 patients

RP: regulatory particle

This marker may reflect shifts in fat utilization, so clinicians may want to monitor it

While there are still gaps in research, some evidence and scientific reasoning can help provide clarity

Repeat: patients typically run 2 cycles per year on this stack